100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.6 TrustPilot
logo-home
Exam (elaborations)

TEST BANK Pharmacotherapeutics for Advanced Practice Nurse Prescribers (6th Ed) by Woo & Wright| All 57 Chapters Covered, Verified Newest Edition

Rating
-
Sold
-
Pages
216
Grade
A+
Uploaded on
27-01-2026
Written in
2025/2026

TEST BANK For Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Woo & Wright Stuvia Is Available For Download After Purchase. In Case You Encounter Any Difficulties with Download or want the document in a Different Format, Please Feel Free to Contact Me via Inbox. I Will Promptly Sort You. Thank You Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Woo & Wright is an essential study tool designed to help you master key pharmacology concepts with confidence. Whether you're a nurse practitioner, advanced practice nurse, or student preparing for exams, this resource provides a comprehensive collection of practice questions to reinforce your understanding of medication management, prescribing guidelines, and therapeutic decision-making. With the Pharmacotherapeutics 6th Edition Test Bank, you can test your knowledge of real-world scenarios and strengthen your clinical reasoning skills. The Woo and Wright Pharmacotherapeutics Test Bank is a valuable companion to your textbook, making complex topics easier to grasp. If you’re looking for a Pharmacotherapeutics Test Bank PDF download, this study aid ensures you’re well-prepared for exams and clinical practice. Ideal for advanced practice nurse prescribers, this test bank offers targeted Pharmacotherapeutics exam questions and answers to enhance your learning. Download the Test Bank for Nurse Prescribers today and gain the confidence needed to excel in your pharmacology coursework and professional practice.' Nurse practitioner prescriptive authority is regulated by: A. The National Council of State Boards of Nursing B. The U.S. Drug Enforcement Administration C. The State Board of Nursing for each state D. The State Board of Pharmacy ANS: C PTS: 1 2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber include: A. Nurses know more about pharmacology than other prescribers because they take it both in their basic nursing program and in their APRN program. B. Nurses care for the patient from a holistic approach and include the patient in decision-making regarding their care. C. APRNs are less likely to prescribe narcotics and other controlled substances. D. APRNs are able to prescribe independently in all states, whereas a physician’s assistant needs to have a physician supervising their practice. ANS: B PTS: 1 3. Clinical judgment in prescribing includes: A. Factoring in the cost to the patient of the medication prescribed B. Always prescribing the newest medication available for the disease process C. Handing out drug samples to poor patients D. Prescribing all generic medications to cut costs ANS: A PTS: 1 4. The process for choosing an effective drug for a disorder includes: A. Asking the patient what drug they think would work best for them B. Consulting nationally recognized guidelines for disease management C. Prescribing medications that are available as samples before writing a prescription D. Following U.S. Drug Enforcement Administration guidelines for prescribing ANS: B PTS: 1 5. Nonintentional nonadherence of drug therapy may occur due to: A. Belief that medication does not work B. Adverse drug reactions C. Chronic conditions that require daily therapy D. Forgetfulness or distraction ANS: D PTS: 1 Woo Pharmacotherapeutics for APN Prescribers, 6e 1 Ch02 Chapter 2. Review of Basic Principles of Pharmacology MULTIPLE CHOICE 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to prescribing because: A. Distribution of drugs to target tissue may be affected. B. The solubility of the drug will not match the site of absorption. C. There will be less free drug available to generate an effect. D. Drugs bound to albumin are readily excreted by the kidneys. ANS: A PTS: 1 2. Drugs that have a significant first-pass effect: A. Must be given by the enteral (oral) route only B. Bypass the hepatic circulation C. Are rapidly metabolized by the liver and may have little, if any, desired action D. Are converted by the liver to more active and fat-soluble forms ANS: C PTS: 1 3. The route of excretion of a volatile drug will likely be the: A. Kidneys B. Lungs C. Bile and feces D. Skin ANS: B PTS: 1 4. A major disadvantage to IV administration is that: A. First-pass metabolism is eliminated. B. Needles and sterility are required. C. Absorption of the drug cannot be slowed after administration. D. It is significantly more expensive than other routes. ANS: C PTS: 1 5. The nurse practitioner (NP) chooses to give cephalexin every 8 hours based on knowledge of the drug’s: A. Propensity to go to the target receptor B. Biological half-life C. Pharmacodynamics D. Safety and side effects ANS: B PTS: 1 6.

Show more Read less
Institution
Pharmacotherapeutics For Advanced Practice 6th Ed
Course
Pharmacotherapeutics for Advanced Practice 6th Ed











Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
Pharmacotherapeutics for Advanced Practice 6th Ed
Course
Pharmacotherapeutics for Advanced Practice 6th Ed

Document information

Uploaded on
January 27, 2026
Number of pages
216
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

  • 9781719648035
  • pharmacotherapeuti

Content preview

TESTBANK ,1,




PharmacotherapeuticsforAdvancedPracticeNursePrescribers,6thEdition
,1, ,1, ,1, ,1, ,1, ,1, ,1,




Author:Teri Moser Woo and WendyL. Wright
,1, ,1, ,1, ,1 , ,1, ,1, ,1,

, TABLE OF CONTENT ,1 , ,1,




Chapter1. The Role of the Advanced Practice Nurse as Prescriber ............................................................................ 4
,1, ,1, ,1, ,1, ,1 , ,1, ,1, ,1 , ,1, ,1,




Chapter2. Review of Basic Principles of Pharmacology .......................................................................................... 5
,1, ,1, ,1, ,1, ,1, ,1, ,1,




Chapter3. Rational Drug Selection ....................................................................................................................... 11
,1, ,1, ,1 , ,1,




Chapter4. Legal and Professional Issues in Prescribing ......................................................................................... 14
,1, ,1, ,1, ,1 , ,1, ,1 , ,1,




Chapter5. Adverse Drug Reactions....................................................................................................................... 16
,1, ,1, ,1 , ,1 ,




Chapter6. An Introduction to Pharmacogenomics................................................................................................. 19
,1, ,1, ,1, ,1, ,1 ,




Chapter7. Nutrition and Nutraceuticals ................................................................................................................ 22
,1, ,1, ,1, ,1,




Chapter8. Herbal Therapies.................................................................................................................................. 28
,1, ,1, ,1,




Chapter9. Cannabis.............................................................................................................................................. 31
,1, ,1,




Chapter10. Pharmacoeconomics .......................................................................................................................... 35
,1, ,1,




Chapter11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
,1, ,1, ,1, ,1 , ,1 , ,1 , ,1,




Chapter12. Drugs Affecting the Central Nervous System ...................................................................................... 45
,1, ,1, ,1, ,1 , ,1 , ,1 , ,1,




Chapter13. Drugs Affecting the Cardiovascular and Renal Systems ...................................................................... 53
,1, ,1, ,1, ,1 , ,1 , ,1, ,1 , ,1,




Chapter14. Drugs Affecting the Respiratory System ............................................................................................. 61
,1, ,1, ,1, ,1 , ,1 , ,1,




Chapter15. Drugs Affecting the Hematological System ........................................................................................ 65
,1, ,1, ,1, ,1, ,1, ,1 ,




Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
,1, ,1, ,1, ,1, ,1, ,1 , ,1, ,1 , ,1,




Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
,1, ,1, ,1, ,1 , ,1 , ,1 , ,1,




Chapter18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
,1, ,1, ,1, ,1, ,1, ,1 ,




Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
,1 ,1 ,1, ,1, ,1, ,1 ,1, ,1 ,1 ,1, ,1,




Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
,1, ,1, ,1, ,1 , ,1 , ,1, ,1 , ,1 , ,1, ,1, ,1 ,




Chapter21. Drugs Affecting the Reproductive System .......................................................................................... 86
,1, ,1, ,1, ,1 , ,1 , ,1 ,




Chapter22. Drugs Affecting the Bones and Joints.................................................................................................. 92
,1, ,1, ,1, ,1 , ,1 , ,1 , ,1,




Chapter23. Drugs Affecting the Integumentary System ........................................................................................ 96
,1, ,1, ,1, ,1 , ,1, ,1,




Chapter24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
,1, ,1, ,1, ,1, ,1 , ,1, ,1,




Chapter25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
,1, ,1, ,1, ,1, ,1 , ,1, ,1 , ,1, ,1, ,1 ,




Chapter26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
,1, ,1, ,1, ,1, ,1 , ,1, ,1,




Chapter27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
,1, ,1, ,1, ,1 , ,1, ,1, ,1, ,1 , ,1,




Chapter28. Anemia ............................................................................................................................................ 113
,1, ,1,




Chapter29. Anxiety and Depression ................................................................................................................... 116
,1, ,1, ,1, ,1,




Chapter30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
,1, ,1, ,1 , ,1,




Chapter31. Asthma and Allergy ......................................................................................................................... 122
,1, ,1, ,1, ,1 ,




Chapter32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
,1, ,1, ,1 , ,1, ,1,




Chapter33. Contraception .................................................................................................................................. 127
,1, ,1,




Chapter34. COVID-19: Acute and Chronic ........................................................................................................ 130
,1, ,1, ,1, ,1, ,1,




Chapter35. Dermatological Conditions .............................................................................................................. 134
,1, ,1, ,1 ,




Chapter36. Diabetes Management ..................................................................................................................... 138
,1, ,1, ,1,




Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
,1, ,1, ,1 , ,1, ,1 , ,1, ,1 ,




Chapter38. Headaches ....................................................................................................................................... 149
,1, ,1,




Chapter39. Heart Failure .................................................................................................................................... 153
,1, ,1, ,1,




Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
,1, ,1, ,1 , ,1 , ,1 , ,1, ,1,




Chapter41. Menopausal Hormone Therapy ........................................................................................................ 161
,1, ,1, ,1, ,1,

,Chapter42. Hyperlipidemia................................................................................................................................ 164
,1, ,1,




Chapter43. Hypertension ................................................................................................................................... 169
,1, ,1,




Chapter44. Hyperthyroidism and Hypothyroidism ............................................................................................. 174
,1, ,1, ,1, ,1,




Chapter45. Obesity ............................................................................................................................................ 177
,1, ,1,




Chapter46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
,1, ,1, ,1, ,1 , ,1 , ,1 , ,1,




Chapter47. Pneumonia ....................................................................................................................................... 185
,1, ,1,




Chapter48. Sexually Transmitted Diseases and Vaginitis.................................................................................... 187
,1, ,1, ,1, ,1 , ,1, ,1,




Chapter49. Substance Use Disorders .................................................................................................................. 190
,1, ,1, ,1 , ,1,




Chapter50. Tuberculosis .................................................................................................................................... 195
,1, ,1,




Chapter51.UpperRespiratoryTractInfection,Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
,1 ,1 ,1 ,1, ,1, ,1, ,1, ,1 ,1 ,1 , ,1 , ,1 ,




Chapter52. Urinary Tract Infections ................................................................................................................... 200
,1, ,1, ,1, ,1,




Chapter53. Women as Patients ........................................................................................................................... 203
,1, ,1, ,1, ,1,




Chapter54. Men as Patients ................................................................................................................................ 207
,1, ,1, ,1, ,1,




Chapter55. Pediatric Patients ............................................................................................................................. 209
,1, ,1, ,1 ,




Chapter57. Geriatric Patients ............................................................................................................................. 213
,1, ,1, ,1 ,

, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e ,1 ,1 ,1, ,1, Ch01


Chapter1.The RoleoftheAdvancedPracticeNurseasPrescriber
,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1,




MULTIPLECHOICE ,1,




1. Nurse practitioner prescriptive authority is regulated by:
,1 , ,1 , ,1 , ,1 , ,1, ,1,




A. The National Council of State Boards ofNursing ,1, ,1 , ,1, ,1, ,1, ,1, ,1,




B. The U.S. Drug Enforcement Administration ,1, ,1, ,1, ,1,




C. TheState Board of Nursing for eachstate ,1, ,1 , ,1, ,1 , ,1, ,1, ,1,




D. The State Board of Pharmacy ,1, ,1, ,1, ,1,




ANS: , 1 , C PTS: , 1 , , 1 , 1

2. Thebenefitstothepatientofhavinganadvancedpracticeregisterednurse(APRN)prescriber
,1 ,1 ,1, ,1 ,1, ,1 ,1, ,1 ,1, ,1, ,1 ,1, ,1




include:
,1,




A. Nursesknowmoreaboutpharmacologythanotherprescribersbecausetheytakeit both ,1 ,1 ,1, ,1, ,1, ,1, ,1, ,1 ,1 ,1, ,1 ,1,




in their basic nursing program and in their APRN program.
,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1,




B. Nursescareforthepatientfromaholisticapproach andincludethepatientin ,1, ,1 ,1 ,1 ,1, ,1, ,1, ,1, ,1 , ,1, ,1 ,1 ,1,




decision-making regarding their care.
,1, ,1, ,1, ,1,




C. APRNs are less likely to prescribe narcotics and other controlledsubstances. ,1, ,1 , ,1, ,1 , ,1 , ,1, ,1, ,1, ,1, ,1




D. APRNsareabletoprescribeindependentlyinallstates,whereasaphysician’s ,1, ,1 ,1 ,1 ,1 ,1, ,1, ,1 ,1 ,1, ,1




assistant needs to have a physician supervising their practice.
,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1,




ANS: , 1 , B PTS: , 1 , , 1 , 1

3. Clinical judgment in prescribing includes: ,1, ,1, ,1 , ,1,




A. Factoringin the cost to the patient of the medication prescribed ,1, ,1, ,1, ,1, ,1 , ,1 , ,1, ,1 , ,1 , ,1 ,




B. Always prescribing the newest medication available for the diseaseprocess ,1, ,1, ,1, ,1, ,1 , ,1 , ,1 , ,1 , ,1




C. Handing out drug samples to poor patients ,1, ,1 , ,1 , ,1, ,1, ,1,




D. Prescribing all generic medications to cutcosts ,1 , ,1, ,1, ,1, ,1, ,1




ANS: , 1 , A PTS: , 1 , , 1 , 1

4. The process for choosing an effective drug for a disorderincludes:
,1, ,1, ,1 , ,1, ,1, ,1 , ,1, ,1, ,1 , ,1




A. Asking the patient what drug they think would work best for them ,1, ,1 , ,1, ,1 , ,1 , ,1, ,1, ,1, ,1, ,1, ,1,




B. Consulting nationally recognized guidelines for diseasemanagement ,1, ,1 , ,1 , ,1 , ,1, ,1




C. Prescribingmedicationsthatareavailableassamplesbeforewritinga prescription ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1, ,1,




D. Following U.S. Drug Enforcement Administration guidelines forprescribing ,1, ,1, ,1, ,1, ,1, ,1, ,1




ANS: , 1 , B PTS: , 1 , , 1 , 1

5. Nonintentional nonadherence of drug therapy may occur due to: ,1 , ,1 , ,1, ,1, ,1, ,1, ,1 , ,1 ,




A. Belief that medication does notwork ,1 , ,1, ,1 , ,1 , ,1,




B. Adverse drug reactions ,1 , ,1,




C. Chronic conditions that requiredailytherapy ,1, ,1, ,1 , ,1, ,1




D. Forgetfulness ordistraction ,1, ,1




ANS: , 1 , D PTS: , 1 , , 1 , 1

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Lectpotter Strayer University
View profile
Follow You need to be logged in order to follow users or courses
Sold
87
Member since
1 year
Number of followers
6
Documents
2412
Last sold
5 hours ago
REALITIEXAMS

Nursing Being my main profession line, My mission is to be your LIGHT in the dark. If you're worried or having trouble in nursing school, I really want my notes to be your guide! I know they have helped countless others get through and that's all I want for YOU! On this page, you find all documents, package deals, and flashcards offered by seller Lectpotter I have essential guides that are Almost A+ graded, I am a very friendly person:

Read more Read less
4.9

181 reviews

5
173
4
1
3
6
2
0
1
1

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions